Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment
Xiaohong Xia(Guangzhou Medical University), Hongbiao Huang(Guangzhou Medical University Cancer Hospital)
Cited by 18
Related Papers
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide
|Journal of Experimental & Clinical Cancer Research|2019|102
Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer
|Journal of Experimental & Clinical Cancer Research|2019|101
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
|Theranostics|2020|74
USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells
|Journal of Experimental & Clinical Cancer Research|2021|58
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
|Cell Death and Disease|2021|44